Ampyra

jhartless's Ampyra History (Ongoing)
Ampyra (dalfampridine (4-ap extended release))
20 mg Daily Jun 10, 2010 - Last Update

jhartless's Ampyra is for…

  • Walking problems

jhartless's side effects of Ampyra…

  • Chronic constipation Jun 12, 2006
  • Dizziness (vertigo) Jun 10, 2010

Evaluations


Jul 12, 2010

  • Perceived effectiveness for Walking problems: Can’t tell
  • Perceived effectiveness for Unsteady gait: Can’t tell
  • Side Effects: Moderate
  • Adherence: Always
  • Burden: Not at all
Dosage: 20 mg Daily
Advice & Tips: I had high hopes, but unfortunately so far I haven't been able to see any change at all in unsteady gait or walking speed.
Cost: $100-199 monthly

About Ampyra (Prescription Drug)

Ampyra™ is the brand name for dalfampridine, an extended release formulation of 4-aminopyridine or 4-AP. Ampyra, a potassium channel blocker, is indicated as a treatment to improve walking in patients with multiple sclerosis.

Learn more about Ampyra in our Ampyra Community Report.